As of 2024-12-06, the Relative Valuation of Heron Therapeutics Inc (HRTX) is (3.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.19 USD, the upside of Heron Therapeutics Inc based on Relative Valuation is -390.5%.
The range of the Relative Valuation is (3.60) - (5.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.3x - 28.6x | 17.7x |
| Forward P/E multiples | 19.6x - 31.2x | 19.9x |
| Fair Price | (3.60) - (5.26) | (3.46) |
| Upside | -402.9% - -542.3% | -390.5% |
| Date | P/E |
| 2024-11-29 | -6.47 |
| 2024-11-27 | -6.31 |
| 2024-11-26 | -5.98 |
| 2024-11-25 | -6.20 |
| 2024-11-22 | -5.82 |
| 2024-11-21 | -5.76 |
| 2024-11-20 | -6.09 |
| 2024-11-19 | -6.47 |
| 2024-11-18 | -6.36 |
| 2024-11-15 | -6.47 |
| 2024-11-14 | -6.74 |
| 2024-11-13 | -6.58 |
| 2024-11-12 | -6.96 |
| 2024-11-11 | -10.01 |
| 2024-11-08 | -9.52 |
| 2024-11-07 | -9.63 |
| 2024-11-06 | -9.79 |
| 2024-11-05 | -9.63 |
| 2024-11-04 | -9.68 |
| 2024-11-01 | -9.68 |
| 2024-10-31 | -9.46 |
| 2024-10-30 | -9.79 |
| 2024-10-29 | -9.63 |
| 2024-10-28 | -10.39 |
| 2024-10-25 | -10.06 |
| 2024-10-24 | -9.68 |
| 2024-10-23 | -9.79 |
| 2024-10-22 | -9.68 |
| 2024-10-21 | -9.84 |
| 2024-10-18 | -9.57 |
| 2024-10-17 | -9.90 |
| 2024-10-16 | -10.17 |
| 2024-10-15 | -9.79 |
| 2024-10-14 | -9.73 |
| 2024-10-11 | -10.01 |
| 2024-10-10 | -9.90 |
| 2024-10-09 | -10.12 |
| 2024-10-08 | -10.44 |
| 2024-10-07 | -10.66 |
| 2024-10-04 | -11.53 |
| 2024-10-03 | -11.26 |
| 2024-10-02 | -11.37 |
| 2024-10-01 | -10.88 |
| 2024-09-30 | -10.82 |
| 2024-09-27 | -10.82 |
| 2024-09-26 | -11.15 |
| 2024-09-25 | -10.28 |
| 2024-09-24 | -10.66 |
| 2024-09-23 | -10.77 |
| 2024-09-20 | -11.20 |